• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Voxel touts FDA-cleared holography

Article

Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95). Voxel uses a

Look for 3-D holography developer Voxel to emphasize the new regulatorystatus of its technology. The Laguna Hills, CA, firm will enjoyits first RSNA meeting with Food and Drug Administration clearancefor its products (SCAN 10/11/95).

Voxel uses a proprietary camera to create VoxGrams, or holographicimages, that seem to reach out into space when they are viewed.Voxel believes the enhanced perspective will help clinicians whenviewing images.

Voxel will show ongoing clinical work using VoxGrams in neurologicaland breast imaging. The company plans to begin beta-site installationsof the system next year.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.